GlycoMimetics Inc (GLYC.OQ)

GLYC.OQ on NASDAQ Stock Exchange Global Market

8.44USD
11:18am EDT
Change (% chg)

-- (+0.00%)
Prev Close
$8.44
Open
$8.47
Day's High
$8.47
Day's Low
$8.44
Volume
363
Avg. Vol
9,683
52-wk High
$12.10
52-wk Low
$6.04

GLYC.OQ

Chart for GLYC.OQ

About

GlycoMimetics, Inc. (GlycoMimetics) is a clinical-stage biotechnology company. The Company focuses on the discovery and development of glycomimetic drugs to address medical needs. The Company is developing a pipeline of glycomimetics that inhibit disease-related functions of carbohydrates, such as the roles they play in... (more)

Overall

Beta: --
Market Cap(Mil.): $158.04
Shares Outstanding(Mil.): 18.99
Dividend: --
Yield (%): --

Financials

  GLYC.OQ Industry Sector
P/E (TTM): -- 188.47 40.23
EPS (TTM): -0.62 -- --
ROI: -41.34 -0.64 15.26
ROE: -41.44 -2.50 16.08
Search Stocks

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $99.46 -0.89
Novartis AG (NOVN.VX) CHF94.75 -1.75
Pfizer Inc. (PFE.N) $34.04 -0.28
Merck & Co., Inc. (MRK.N) $60.56 -0.08
Roche Holding Ltd. (ROG.VX) CHF267.10 -1.90
Bayer AG (BAYGn.DE) €126.45 -3.65
Bayer AG (BAYE.F) -- --

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Ford Investor Services, Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks